Literature DB >> 24659449

Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia.

Hai-rong He, Xiao-xia Zhang, Jin-yue Sun, Sa-sa Hu, Ying Ma, Ya-lin Dong, Jun Lu.   

Abstract

Glutathione S-transferase (GST), a phase II metabolizing enzyme, plays an important role in the cellar defense system, and its activity may modulate leukemia risk. A large body of evidence has shown the possible relevance of functional polymorphisms of the genes that encode GSTs μ, π, and θ (GSTM1, GSTP1, and GST1, respectively) to the genetic susceptibility of chronic myeloid leukemia (CML). Because of the lack of available conclusive data, we performed a meta-analysis of all relevant available studies to derive a more precise estimation of the relationship. A comprehensive literature search of PubMed and Web of Knowledge electronic databases was conducted to collect relevant studies until December 20, 2013, and the extracted data were statistically analyzed using Review Manager version 5.2. Finally, 16 eligible studies were identified in the literature. The GSTT1 null genotype was associated with an increased risk of CML, as were the double null GSTT1 and GSTM1 genotypes. These findings suggest that heritable GST status influences the risk of developing CML and that more attention should be paid to carriers of these susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24659449     DOI: 10.1007/s13277-014-1810-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes.

Authors:  M T Voso; E Fabiani; F D'Alo'; F Guidi; A Di Ruscio; S Sica; L Pagano; M Greco; S Hohaus; G Leone
Journal:  Ann Oncol       Date:  2007-09       Impact factor: 32.976

Review 2.  Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis.

Authors:  Ronit Gurion; Anat Gafter-Gvili; Liat Vidal; Avi Leader; Ron Ram; Adi Shacham-Abulafia; Mical Paul; Isaac Ben-Bassat; Ofer Shpilberg; Pia Raanani
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

3.  Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias.

Authors:  M C Lemos; F J Cabrita; H A Silva; M Vivan; F Plácido; F J Regateiro
Journal:  Carcinogenesis       Date:  1999-07       Impact factor: 4.944

4.  Variations in glutathione-S-transferase genes influence risk of chronic myeloid leukemia.

Authors:  Nur Özten; Asuman Sunguroğlu; Maarten C Bosland
Journal:  Hematol Oncol       Date:  2011-10-04       Impact factor: 5.271

5.  GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese.

Authors:  Asahi Hishida; Seitaro Terakura; Nobuhiko Emi; Kazuhito Yamamoto; Makoto Murata; Kazuko Nishio; Yoshitaka Sekido; Toshimitsu Niwa; Nobuyuki Hamajima; Tomoki Naoe
Journal:  Asian Pac J Cancer Prev       Date:  2005 Jul-Sep

6.  DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group.

Authors:  D Bhatla; R B Gerbing; T A Alonzo; P A Mehta; K Deal; J Elliott; S Meshinchi; H Geiger; J P Perentesis; B J Lange; S M Davies
Journal:  Leukemia       Date:  2007-11-22       Impact factor: 11.528

7.  Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.

Authors:  Han-Chun Chen; Wei-Xin Hu; Qing-Xia Liu; Wen-Kai Li; Fang-Zhi Chen; Zhou-Zhou Rao; Xin-Fa Liu; Ya-Ping Luo; Yan-Fei Cao
Journal:  Eur J Cancer Prev       Date:  2008-06       Impact factor: 2.497

8.  Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia.

Authors:  Prabhavathy Das; Abjal Pasha Shaik; Vamsee K Bammidi
Journal:  Leuk Lymphoma       Date:  2009-08

9.  Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia.

Authors:  Prachi Bajpai; Anil Kumar Tripathi; Deepa Agrawal
Journal:  Leuk Res       Date:  2007-04-08       Impact factor: 3.156

Review 10.  A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.

Authors:  E Lopez-Lopez; I Martin-Guerrero; J Ballesteros; A Garcia-Orad
Journal:  Pharmacogenomics J       Date:  2012-10-23       Impact factor: 3.550

View more
  11 in total

1.  A meta-analysis of glutathione S-transferase M1 and T1 genetic polymorphism in relation to susceptibility to nasopharyngeal carcinoma.

Authors:  Rong-Rong Liu; Ji-Chuan Chen; Ming-Dong Li; Te Li; Yun Tan; Min Zhang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Green tea consumption and glutathione S-transferases genetic polymorphisms on the risk of adult leukemia.

Authors:  Ping Liu; Min Zhang; Xing Xie; Jie Jin; C D'Arcy J Holman
Journal:  Eur J Nutr       Date:  2015-11-17       Impact factor: 5.614

3.  CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case-control study.

Authors:  Claudia Bănescu; Adrian P Trifa; Septimiu Voidăzan; Valeriu G Moldovan; Ioan Macarie; Erzsebeth Benedek Lazar; Delia Dima; Carmen Duicu; Minodora Dobreanu
Journal:  Oxid Med Cell Longev       Date:  2014-11-11       Impact factor: 6.543

4.  Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis.

Authors:  Zhiwang Song; Chuan Shao; Chan Feng; Yonglin Lu; Yong Gao; Chunyan Dong
Journal:  Ther Clin Risk Manag       Date:  2016-05-12       Impact factor: 2.423

Review 5.  Significance of Polymorphisms and Expression of Enzyme-Encoding Genes Related to Glutathione in Hematopoietic Cancers and Solid Tumors.

Authors:  Szymon Zmorzyński; Grażyna Świderska-Kołacz; Dorota Koczkodaj; Agata Anna Filip
Journal:  Biomed Res Int       Date:  2015-11-23       Impact factor: 3.411

6.  Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response.

Authors:  Golale Rostami; Dlnya Assad; Fatemeh Ghadyani; Mohammad Hamid; Amirhossien Karami; Hasan Jalaeikhoo; Ramezan Ali Kalahroodi
Journal:  Mol Genet Genomic Med       Date:  2019-05-20       Impact factor: 2.183

7.  Combined GSTT1 Null, GSTM1 Null and XPD Lys/Lys Genetic Polymorphisms and Their Association with Increased Risk of Chronic Myeloid Leukemia.

Authors:  Ezeldine K Abdalhabib; Denise E Jackson; Badr Alzahrani; Elyasa M Elfaki; Alneil Hamza; Fehaid Alanazi; Elryah I Ali; Abdulrahman Algarni; Ibrahim Khider Ibrahim; Muhammad Saboor
Journal:  Pharmgenomics Pers Med       Date:  2021-12-22

8.  GSTT1 null and rs156697 Polymorphism in GSTO2 Influence the Risk and Therapeutic Outcome of B-Acute Lymphoblastic Leukemia Patients.

Authors:  Shahid M Baba; Arshad A Pandith; Zafar A Shah; Sajad A Geelani; Javid R Bhat; Ayaz Gul; Sameer A Guru; Hamed A El-Serehy; Abid M Koul; Sheikh Mansoor
Journal:  Front Oncol       Date:  2021-10-14       Impact factor: 6.244

9.  From Six Gene Polymorphisms of the Antioxidant System, Only GPX Pro198Leu and GSTP1 Ile105Val Modulate the Risk of Acute Myeloid Leukemia.

Authors:  Claudia Bănescu; Mihaela Iancu; Adrian P Trifa; Marcela Cândea; Erzsebet Benedek Lazar; Valeriu G Moldovan; Carmen Duicu; Florin Tripon; Andrei Crauciuc; Minodora Dobreanu
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

Review 10.  Re-evaluation of the WHO (2010) formaldehyde indoor air quality guideline for cancer risk assessment.

Authors:  Gunnar Damgård Nielsen; Søren Thor Larsen; Peder Wolkoff
Journal:  Arch Toxicol       Date:  2016-05-21       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.